Cargando…

Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is an increasingly prevalent disease that is associated with multiple metabolic disturbances, yet the metabolic pathways underlying its progression are poorly understood. Here, we studied metabolic pathways of the human liver across the full histological spec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sen, Partho, Govaere, Olivier, Sinioja, Tim, McGlinchey, Aidan, Geng, Dawei, Ratziu, Vlad, Bugianesi, Elisabetta, Schattenberg, Jörn M., Vidal-Puig, Antonio, Allison, Michael, Cockell, Simon, Daly, Ann K., Hyötyläinen, Tuulia, Anstee, Quentin M., Orešič, Matej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440293/ https://www.ncbi.nlm.nih.gov/pubmed/36065182 http://dx.doi.org/10.1016/j.isci.2022.104949

Ejemplares similares

Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
por: McGlinchey, Aidan J., et al.
Publicado: (2022)

Metabolic Signatures of the Exposome—Quantifying the Impact of Exposure to Environmental Chemicals on Human Health
por: Orešič, Matej, et al.
Publicado: (2020)

A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
por: Govaere, Olivier, et al.
Publicado: (2023)

Potential Transdiagnostic Lipid Mediators of Inflammatory Activity in Individuals With Serious Mental Illness
por: Hylén, Ulrika, et al.
Publicado: (2021)

Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
por: Johnson, Katherine, et al.
Publicado: (2021)

Exposure to persistent organic pollutants alters the serum metabolome in non-obese diabetic mice
por: Sinioja, Tim, et al.
Publicado: (2022)

Linking Gut Microbiome and Lipid Metabolism: Moving beyond Associations
por: Lamichhane, Santosh, et al.
Publicado: (2021)

42.3 METABOLOMICS APPROACHES TO STUDY METABOLIC CO-MORBIDITIES IN PSYCHOTIC DISORDERS
por: Hyötyläinen, Tuulia, et al.
Publicado: (2018)

The Gut Microbiota Modulates Glycaemic Control and Serum Metabolite Profiles in Non-Obese Diabetic Mice
por: Greiner, Thomas U., et al.
Publicado: (2014)

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease
por: Boyle, Marie, et al.
Publicado: (2019)

Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease
por: Hyötyläinen, Tuulia, et al.
Publicado: (2016)

Metabolomics Profiling As a Diagnostic Tool in Severe Traumatic Brain Injury
por: Posti, Jussi P., et al.
Publicado: (2017)

4β-Hydroxycholesterol Signals From the Liver to Regulate Peripheral Cholesterol Transporters
por: Salonurmi, Tuire, et al.
Publicado: (2020)

Persistent Alterations in Plasma Lipid Profiles Before Introduction of Gluten in the Diet Associated With Progression to Celiac Disease
por: Sen, Partho, et al.
Publicado: (2019)

Lipidomic Analyses Reveal Modulation of Lipid Metabolism by the PFAS Perfluoroundecanoic Acid (PFUnDA) in Non-Obese Diabetic Mice
por: Hyötyläinen, Tuulia, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease: new treatments
por: Hardy, Timothy, et al.
Publicado: (2015)

Targeted Serum Metabolite Profiling Identifies Metabolic Signatures in Patients with Alzheimer's Disease, Normal Pressure Hydrocephalus and Brain Tumor
por: Orešič, Matej, et al.
Publicado: (2018)

Cord serum metabolic signatures of future progression to immune-mediated diseases
por: Hyötyläinen, Tuulia, et al.
Publicado: (2023)

Dysregulation of secondary bile acid metabolism precedes islet autoimmunity and type 1 diabetes
por: Lamichhane, Santosh, et al.
Publicado: (2022)

Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2021)

Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children
por: Lamichhane, Santosh, et al.
Publicado: (2023)

Metabolic Modeling of Human Gut Microbiota on a Genome Scale: An Overview
por: Sen, Partho, et al.
Publicado: (2019)

Integrating Omics Data in Genome-Scale Metabolic Modeling: A Methodological Perspective for Precision Medicine
por: Sen, Partho, et al.
Publicado: (2023)

Age- and Islet Autoimmunity–Associated Differences in Amino Acid and Lipid Metabolites in Children at Risk for Type 1 Diabetes
por: Pflueger, Maren, et al.
Publicado: (2011)

Mondo/ChREBP-Mlx-Regulated Transcriptional Network Is Essential for Dietary Sugar Tolerance in Drosophila
por: Havula, Essi, et al.
Publicado: (2013)

Decreased Cord-Blood Phospholipids in Young Age–at–Onset Type 1 Diabetes
por: La Torre, Daria, et al.
Publicado: (2013)

Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients
por: Ahonen, Linda, et al.
Publicado: (2019)

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
por: Labenz, Christian, et al.
Publicado: (2020)

Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver disease
por: Karsdal, Morten A., et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression
por: Labenz, Christian, et al.
Publicado: (2020)

Metabolic alterations in immune cells associate with progression to type 1 diabetes
por: Sen, Partho, et al.
Publicado: (2020)

Simultaneous determination of perfluoroalkyl substances and bile acids in human serum using ultra-high-performance liquid chromatography–tandem mass spectrometry
por: Salihović, Samira, et al.
Publicado: (2019)

Impact of Extensively Hydrolyzed Infant Formula on Circulating Lipids During Early Life
por: Lamichhane, Santosh, et al.
Publicado: (2022)

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
por: Orešič, Matej, et al.
Publicado: (2013)

Correction of Liver Steatosis by a Hydrophobic Iminosugar Modulating Glycosphingolipids Metabolism
por: Lombardo, Elisa, et al.
Publicado: (2012)

Perspectives on Systems Modeling of Human Peripheral Blood Mononuclear Cells
por: Sen, Partho, et al.
Publicado: (2018)

Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
por: Donati, Benedetta, et al.
Publicado: (2017)

Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis
por: Kozumi, Kazuhiro, et al.
Publicado: (2021)

Dynamics of the Lipidome in a Colon Simulator
por: Kråkström, Matilda, et al.
Publicado: (2023)

Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver
por: Kotronen, Anna, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jlilg6l08urtt3or36pqmtf7cf